A trio of researchers from the University of São Paulo (USP) and São Paulo State University (UNESP) in Brazil has developed a ...
Under the new priority voucher program (CNPV), the FDA has approved a new oral GLP-1 drug, Foundayo, offering an alternative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results